AI-driven Molecular Glue Innovation: Insilico Nominates ISM9546, an Oral, Peripheral-Restricted VAV1 Degrader as PCC for Autoimmune Diseases Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/5070666_CN70666_0